Accepted at 11:56 a.m. Jan, 06, 2025 by Ahmed7
Author: alwaysjennuine
Co-authors: Ahmed7
Related Note: 1485220042805 1
Rationale for change

Important to highlight the two 2nd generation antipsychotics that are greatest risk for this adverse effect
Source: UWorld - Step 1 11848

Extra Extra
Text
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Picmonic
Empty field
Pixorize
Physeo
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step2_v12::#UWorld::Step::4885 #AK_Step2_v12::#Resources_by_rotation::Psych::fapsych::pharm #AK_Step1_v12::#OME::Clinical::Pediatrics/Psychiatry #AK_Step1_v12::#Pixorize::03_Pharmacology::17_Psych_Pharm::New::09_Atypical_Antipsychotics #AK_Step1_v12::^Systems::Neuro::Pharmacology #AK_Step1_v12::#Bootcamp::Psychiatry::09_Pharmacology::14_Atypical_Antipsychotics #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step2_v12::#UWorld::Step::11958 #AK_Step2_v12::#AMBOSS::oL00Ag #AK_Step2_v12::#B&B::13_Psych::04_Psychopharmacology::02_Antipsychotics::Extra #AK_Other::AnKing_Image::!Subjects::Cardiology::Metabolic_Syndrome #AK_Step2_v12::#Resources_by_rotation::FM::ome::psych::pharm #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::16_Atypical_Antipsychotics #AK_Step1_v12::#Pixorize::03_Pharmacology::17_Psych_Pharm::03_Atypical_Antipsychotics #AK_Step2_v12::!Shelf::FM::no_dupes #AK_Other::AnKing_Image::AhmedA::Metabolic_Syndrome #AK_Step2_v12::#Resources_by_rotation::Psych::fapsych::psychotic_disorders #AK_Step2_v12::#OME::04_Psychiatry::15_Psych_Pharm_2 #AK_Step2_v12::#Subjects::Psychiatry::07_Psychotic_Disorders::*Antipsychotics::Typical_Antipsychotics::Basics #AK_Step1_v12::#B&B::19_Psych::04_Pharm::03_Antipsychotics::Extra #AK_Step1_v12::#Pixorize::^Missing_image #AK_Step2_v12::#SketchyIM::05_Endocrinology::01_Diabetes_Mellitus::01_Diabetes_SOAP #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::04_Antipsychotics_&_Parkinsons::01_First-Generation_Antipsychotics #AK_Step2_v12::#AMBOSS::9H0Nsh #AK_Step1_v12::#UWorld::Step::11848 #AK_Step2_v12::Original_decks::Dorian::psych::fapsych::pharm #AK_Step2_v12::#OME::04_Psychiatry::07_Psychotic_Disorders #AK_Step2_v12::!Shelf::Psych::no_dupes #AK_Step2_v12::#AMBOSS::YFangm #AK_Step1_v12::#Physeo::^physeo_image_update #AK_Step1_v12::#SketchyPharm::06_Neuro_&_Psych::04_Antipsychotics_&_Parkinsons::02_Second-Generation_Antipsychotics #AK_Step2_v12::Original_decks::Dorian::fam::ome::psych::pharm #AK_Step1_v12::#FirstAid::13_Psych::03_Pharm::03_Antipsychotics::*Atypical_Antipsychotics #AK_Step1_v12::#UWorld::COMLEX::25734 #AK_Step2_v12::#UWorld::COMLEX::101967 #AK_Step2_v12::#Subjects::Psychiatry::07_Psychotic_Disorders::*Antipsychotics::Atypical_Antipsychotics::*Basics #AK_Other::Only_Step_1&2_Overlap #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology